Oxytocin: Reference Overview and Reconstitution Notes

July 9, 2026

Oxytocin

What it is

Oxytocin is a naturally occurring nonapeptide, a hormone built from nine amino acids that is produced in the hypothalamus and released by the posterior pituitary gland. The synthetic form used in medicine and research is chemically identical to the endogenous molecule and is closely related to vasopressin, differing from it by only two amino acids.

Research context and categorization

Oxytocin spans two overlapping categories. In its approved medical role it is a reproductive and obstetric agent, specifically a uterotonic that acts on smooth muscle of the uterus. Separately, it is one of the most studied compounds in social and behavioral neuroscience, where it is usually grouped under cognitive, mood, and social bonding research.

Within the reproductive category, oxytocin is established for stimulating uterine contractions during labor and for helping control bleeding after delivery, and those obstetric uses are FDA-approved. Within the behavioral category, it is commonly discussed in relation to social bonding, attachment, trust, and affiliative behavior, and intranasal formulations have been investigated for autism spectrum conditions and for anxiety. These behavioral and psychiatric uses are investigational and not FDA-approved. Published trials in this area have produced mixed and inconsistent results, so any social, emotional, or cognitive effects are better treated as open research questions than as established benefits.

Status

Regulatory status: FDA-approved for specific obstetric indications, including initiation or improvement of uterine contractions where medically indicated and control of postpartum uterine bleeding. It is marketed for these uses as a prescription injectable, for example under the brand name Pitocin. Intranasal and other non-obstetric uses studied in behavioral research are investigational and not FDA-approved, and lyophilized powder sold to laboratories is offered as research-use-only material.
Sport status: Not specifically listed on the WADA Prohibited List. Oxytocin is not named among the prohibited peptide hormones, growth factors, or hormone and metabolic modulators. Athletes should still confirm current status directly, since list interpretations and the non-approved-substances clause can apply case by case.

Reconstitution notes (general)

When supplied as a lyophilized (freeze-dried) powder, oxytocin is reconstituted before use. The resulting concentration is simply the amount in the vial divided by the volume of diluent added, so milligrams in the vial divided by millilitres of bacteriostatic water added gives milligrams per millilitre. A reconstitution calculator is available at /pages/tools.

Dilution and handling notes (compound-specific)

Oxytocin exists in more than one form, which changes how it is handled. The pharmaceutical product is often supplied as a ready-to-use sterile liquid in ampoules or vials, which needs no reconstitution and is simply drawn as provided. Research-grade material, by contrast, is commonly sold as a lyophilized powder, frequently in 5 mg or 10 mg vials, and that is the form that gets reconstituted.

For the powder, a common approach is to add roughly 3 mL of bacteriostatic water per vial, which yields about 1.67 mg/mL for a 5 mg vial or about 3.33 mg/mL for a 10 mg vial. The exact volume is chosen to reach whatever working concentration is intended, and some workers use larger volumes to make a lower, more measurable concentration, so the choice is mostly about convenience rather than any solubility limit. Bacteriostatic water (sterile water with about 0.9 percent benzyl alcohol as a preservative) is the usual diluent because a reconstituted vial is meant to be stored and drawn from repeatedly rather than used all at once.

Oxytocin is a small, water-soluble peptide and generally dissolves readily, so diluent is added gently down the inside wall of the vial and the vial is swirled, not shaken, until the solution is clear. It does not typically gel or precipitate the way some larger or more hydrophobic peptides do. The main practical quirk is stability rather than solubility: vigorous shaking, vortexing, or sonication introduces air-water interface stress and foaming that can promote aggregation, and the peptide in solution is also sensitive to heat and light and degrades over time. It is therefore kept cold and dark, foam is allowed to settle before drawing, and repeated freeze-thaw cycling is avoided because it can damage the peptide. Because intranasal delivery is common in behavioral research, the reconstituted solution is sometimes transferred into a calibrated spray bottle, in which case bacteriostatic water remains the appropriate diluent for any container used more than once. A batch that stays cloudy, gels, or shows visible particles after gentle swirling is treated as suspect rather than forced into solution.

Handling and storage

Store reconstituted oxytocin refrigerated at 2 to 8 degrees Celsius and keep it out of direct light. Wipe the rubber stopper with an alcohol swab before each puncture, and label the vial with the reconstitution date so its age is always clear. Observe the general reference window of roughly four weeks refrigerated for a mixed vial, and discard anything that has turned cloudy, changed color, or shows floaters.

Tools and supplies

For laboratory and research reference only. Educational content, not medical, dosing, injection, or therapeutic guidance, and not intended for human or animal use. Any research uses described are investigational and not confirmed or approved benefits. Confirm anything involving health with a licensed professional. References linked above.